IONIS PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ionis Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Ionis Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $164M, a 5.67% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $164M -$9.89M -5.67% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $167M -$9.78M -5.53% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $169M -$9.72M -5.42% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $172M -$9.65M -5.31% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $174M Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $177M Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $179M Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $182M +$164M +910% Dec 31, 2022 10-K 2024-02-21
Q4 2021 $18M +$4.87M +37.2% Dec 31, 2021 10-K 2023-02-22
Q4 2020 $13.1M +$500K +3.97% Dec 31, 2020 10-K 2021-02-24
Q4 2019 $12.6M Dec 31, 2019 10-K 2020-03-02
Q3 2019 $13M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $12.9M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $13.1M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.